Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1986 Jun;45(6):508–511. doi: 10.1136/ard.45.6.508

Rheumatoid factor in rheumatoid arthritis associated renal disease and in lupus nephritis.

H Helin, M Korpela, J Mustonen, A Pasternack
PMCID: PMC1001924  PMID: 3729575

Abstract

To test the hypothesis that rheumatoid factor (RF) protects against (immune complex mediated) renal disease, patients with rheumatoid arthritis (RA; 48 with nephropathy of various types, 35 without renal disease) and systemic lupus erythematosus (SLE; 35 with and 17 without nephritis) were evaluated for the presence and titre of RF. There was no correlation between RF and nephropathy in RA, whereas in SLE RFs were almost exclusively seen in patients without nephropathy. This result supports the above hypothesis for lupus nephropathy but not for RA associated renal disease, and it may be explained by a more pronounced role for immune complexes in SLE and interference of RFs with the complexes.

Full text

PDF
508

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello V. The immunopathogenesis of lupus nephritis. Adv Nephrol Necker Hosp. 1976;6:119–136. [PubMed] [Google Scholar]
  2. Baldwin D. S., Lowenstein J., Rothfield N. F., Gallo G., McCluskey R. T. The clinical course of the proliferative and membranous forms of lupus nephritis. Ann Intern Med. 1970 Dec;73(6):929–942. doi: 10.7326/0003-4819-73-6-929. [DOI] [PubMed] [Google Scholar]
  3. Bolton W. K., Schrock J. H., Davis J. S., 4th Rheumatoid factor inhibition of in vitro binding of IgG complexes in the human glomerulus. Arthritis Rheum. 1982 Mar;25(3):297–303. doi: 10.1002/art.1780250307. [DOI] [PubMed] [Google Scholar]
  4. DAVIS J. S., 4th, BOLLET A. J. PROTECTION OF A COMPLEMENT-SENSITIVE ENZYME SYSTEM BY RHEUMATOID FACTOR. J Immunol. 1964 Jan;92:139–144. [PubMed] [Google Scholar]
  5. EDELMAN G. M., KUNKEL H. G., FRANKLIN E. C. Interaction of the rheumatoid factor with antigen-antibody complexes and aggregated gamma globulin. J Exp Med. 1958 Jul 1;108(1):105–120. doi: 10.1084/jem.108.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ford P. M., Kosataka I. The effect of human IgM rheumatoid factor on renal glomerular immune complex deposition in passive serum sickness in the mouse. Immunology. 1982 Aug;46(4):761–768. [PMC free article] [PubMed] [Google Scholar]
  7. Ford P. M., Kosatka I. In situ immune complex formation in the mouse glomerulus: reactivity with human IgM rheumatoid factor and the effect on subsequent immune complex deposition. Clin Exp Immunol. 1983 Feb;51(2):285–291. [PMC free article] [PubMed] [Google Scholar]
  8. Germuth F. G., Rodriguez E. Effect of human IgM rheumatoid factor on the glomerular site of localization of passively administered immune complexes in mice. Immunology. 1984 Oct;53(2):395–398. [PMC free article] [PubMed] [Google Scholar]
  9. Gordon D. A., Stein J. L., Broder I. The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases. Am J Med. 1973 Apr;54(4):445–452. doi: 10.1016/0002-9343(73)90040-5. [DOI] [PubMed] [Google Scholar]
  10. HEIMER R., LEVIN F. M., KAHN M. F. INHIBITION OF COMPLEMENT FIXATION BY HUMAN SERUM. II. THE ACTIVITY OF A GAMMA-LM GLOBULIN AND RHEUMATOID FACTOR IN COMPLEMENT FIXATION REACTIONS. J Immunol. 1963 Dec;91:866–872. [PubMed] [Google Scholar]
  11. Helin H., Korpela M., Mustonen J., Pasternack A. Mild mesangial glomerulopathy--a frequent finding in rheumatoid arthritis patients with hematuria or proteinuria. Nephron. 1986;42(3):224–230. doi: 10.1159/000183671. [DOI] [PubMed] [Google Scholar]
  12. Hill G. S., Hinglais N., Tron F., Bach J. F. Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy. Am J Med. 1978 Jan;64(1):61–79. doi: 10.1016/0002-9343(78)90180-8. [DOI] [PubMed] [Google Scholar]
  13. Izui S., Lambert P. H., Miescher P. A. In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA. A possible basis for a local formation of DNA-anti-DNA complexes in systemic lupus erythematosus. J Exp Med. 1976 Aug 1;144(2):428–443. doi: 10.1084/jem.144.2.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kantor G. L., Bickel Y. B., Barnett E. V. Coexistence of systemic lupus erythematosus and rheumatoid arthritis. Report of a case and review of the literature, with clinical, pathologic and serologic observations. Am J Med. 1969 Sep;47(3):433–444. doi: 10.1016/0002-9343(69)90227-7. [DOI] [PubMed] [Google Scholar]
  15. Klinefelter H. F., Achurra A. Effect of gold salts and antimalarials on the rheumatoid factor in rheumatoid arthritis. Scand J Rheumatol. 1973;2(4):177–182. doi: 10.3109/03009747309097086. [DOI] [PubMed] [Google Scholar]
  16. Maury C. P., Teppo A. M. Rheumatoid factors and amyloidosis in rheumatoid arthritis. Br Med J (Clin Res Ed) 1985 Oct 12;291(6501):1015–1016. doi: 10.1136/bmj.291.6501.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McCluskey R. T. The value of the renal biopsy in lupus nephritis. Arthritis Rheum. 1982 Jul;25(7):867–875. doi: 10.1002/art.1780250731. [DOI] [PubMed] [Google Scholar]
  18. McCormick J. N., Day J., Morris C. J., Hill A. G. The potentiating effect of rheumatoid arthritis serum in the immediate phase of nephrotoxic nephritis. Clin Exp Immunol. 1969 Jan;4(1):17–28. [PMC free article] [PubMed] [Google Scholar]
  19. ROPES M. W., BENNETT G. A., COBB S., JACOX R., JESSAR R. A. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed] [Google Scholar]
  20. Skrifvars B. V., Törnroth T. S., Tallqvist G. N. Gold-induced immune complex nephritis in seronegative rheumatoid arthritis. Ann Rheum Dis. 1977 Dec;36(6):549–556. doi: 10.1136/ard.36.6.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  22. Van Snick J. L., Van Roost E., Markowetz B., Cambiaso C. L., Masson P. L. Enhancement by IgM rheumatoid factor of in vitro ingestion by macrophages and in vivo clearance of aggregated IgG or antigen-antibody complexes. Eur J Immunol. 1978 Apr;8(4):279–285. doi: 10.1002/eji.1830080412. [DOI] [PubMed] [Google Scholar]
  23. Viol G. W., Minielly J. A., Bistricki T. Gold nephropathy: tissue analysis by X-ray fluorescent spectroscopy. Arch Pathol Lab Med. 1977 Dec;101(12):635–640. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES